• Copaxid is a combination of Nirmatrelvir (150mg) and Ritonavir (100mg), an antiviral treatment used to manage COVID-19 in patients with mild to moderate symptoms who are at high risk of progression to severe illness.
• Active ingredients: Nirmatrelvir 150mg and Ritonavir 100mg.
• Indication: Used to treat mild to moderate COVID-19 in adults and adolescents (12 years and older, weighing at least 40 kg) who are at high risk for severe illness.
• Dose: as prescribed by the physician.